Answers are grounded in this paper and cite their sources.
Gene therapy is entering the stage of initial clinical development to treat a growing number of inherited metabolic diseases. This review outlines the development of liver-directed gene therapy for diseases caused by deficiencies of enzymes that are primarily expressed in the liver and discusses the disorders that appear most promising for clinical translation.
No takes yet. Share an insight, caveat, or question.
Piccolo et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: